Humana’s digital health hub ramping up new projects

Amy Baxter | | Health Exec | Digital Transformation

Source

istock

Health insurance giant Humana is hoping to make its new digital health hub in Boston look and feel like a technology startup. Over the past six months, the digital health branch, led by Heather Cox, has hired 75 developers in Boston, CNBC reported.

The new team is building out a virtual primary care service with a telemedicine platform, Dr. on Demand. The project is scheduled to launch for small Medicare plans in 2020, CNBC reported. The new digital initiatives will likely help Humana leverage its large home care business. The company acquired Kindred at Home last year.

The new branch in Boston will also likely ramp up even more––Humana received a tax credit of $225,000 from Massachusetts to create up to 300 new jobs over the next five years.

See the full story below:

Behind the scenes at Humana’s new digital health unit in Boston

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

4 points crucial to the nimble regulation of GenAI
5 tips to learn AI from scratch and for free
Good AI governance can spell the difference between smashing success and mere learning experience
10 ways AI, robotics are improving pediatric care in real-world settings
Partnership on AI valiantly trying to wrap arms around the world
How the FDA sees its role vis-à-vis AI in healthcare

Around the web

AI in Healthcare
4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Design by Adaptive Theme
Trimed Popup
Trimed Popup